Primary Biliary Cholangitis: 2018 Practice Guidance from the American Association for the Study of Liver Diseases

Lindor, Keith D., Bowlus, Christopher L., Boyer, James, Levy, Cynthia, Mayo, Marlyn·2019·Hepatology

Cited by (924)

Items 501–600 of 924

  1. Classic Autoimmune Liver Disorders and Celiac Hepatitis
    Muhammad Amir, Samir Parekh · 2021 · Clinical Liver Disease
  2. Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R‐LIVER)
    Alessio Gerussi, Eugenia Nofit, Davide Paolo Bernasconi, C. Kroll, F. Groß, Ida Schregel, Alberto Marini, Laura Cristoferi, Federica Malinverno, Mária Papp et al. · 2025 · United European Gastroenterology Journal
  3. Profile of Patients with Primary Biliary Cholangitis and Evaluation of Response to Ursodeoxycholic Acid in a Romanian Center—Retrospective Study
    Matei Mandea, Speranta Maria Iacob, Mihaela Corina Ghioca, Cristian Gheorghe, Liliana Simona Gheorghe · 2025 · Journal of Clinical Medicine
  4. Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in Adults
    Ahmad Basil Nasir, Naim Alkhouri, Robert Gareth Gish · 2025 · Digestive Diseases and Sciences
  5. Current and future opportunities for the management of primary biliary cholangitis
    Sandra Naffouj, Jennifer Rui Wang · 2023 · Frontiers in Gastroenterology
  6. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome
    Michelle Harriz Braga, Guilherme Grossi Lopes Cançado, Paulo Lisboa Bittencourt, Cláudia Alves Couto, Laura Vilar Guedes, André Mourão Costa Lima, Maria Lúcia Gomes Ferraz, Cristiane Alves Villela‐Nogueira, Mateus Jorge Nardelli, Luciana Costa Faria et al. · 2023 · Annals of Hepatology
  7. Breaking Grounds: A Comprehensive Analysis of Cutting-Edge Treatments for Primary Biliary Cirrhosis/Primary Biliary Cholangitis With Futuristic Treatments
    Asad Ali Khan, Furqan Ul Haq, Qazi Muhammad Farooq Wahab, Taimur Aslam, Azeem Khalid, Asad Abu Bakar Ali · 2025 · Cureus
  8. Cross‐Phenotype Genome‐Wide Association Study on the Shared Genetic Susceptibility to Systemic Sclerosis and Primary Biliary Cholangitis
    Yiming Luo, Atlas Khan, Lili Liu, Cue Hyunkyu Lee, Gabriel J. Perreault, Sydney F. Pomenti, Pravitt Gourh, Krzysztof Kiryluk, Elana J. Bernstein · 2024 · Arthritis & Rheumatology
  9. Definition and validation of recompensation in patients with primary biliary cholangitis-related decompensated cirrhosis treated with ursodeoxycholic acid: Based on the BAVENO VII criteria
    Dawei Ding, Lina Cui, Gui Jia, Boling Wang, Linhua Zheng, Juan Deng, Ruiqing Sun, Xiufang Wang, Yulong Shang, Guanya Guo et al. · 2025 · Journal of Translational Internal Medicine
  10. Clinical significance of anti-mitochondrial antibodies and PBC-specific anti-nuclear antibodies in evaluating atypical primary biliary cholangitis with normal alkaline phosphatase levels
    Shasha Li, Kai Zhang, Hongli Liu, Miaoyang Chen, Jialuo Wang, Yuan Yang, Yuxiang Gong, Xing Liu, Yongfeng Yang · 2025 · Clinical Chemistry and Laboratory Medicine (CCLM)
  11. Noninvasive prediction of insufficient biochemical response after ursodeoxycholic acid treatment in patients with primary biliary cholangitis based on pretreatment nonenhanced MRI
    Yun Zhang, Xiaoli Fan, Bin Song, Yifeng Liu, Yidi Chen, Tianying Zheng, Yuxin Guo, Ting Duan, Zixing Huang, Li Yang · 2023 · European Radiology
  12. Spanish clinical practice guidelines for the diagnosis and management of cholestatic liver diseases in adult and pediatric population: Joint report from AEEH and SEGHNP
    Álvaro Díaz‐González, Cristina Molera, Elena Gómez Domínguez, Gema Muñoz‐Bartolo, Javier Ampuero, Conrado Fernández‐Rodríguez, Jesús Quintero, Esther Molina, Magdalena Salcedo, Antonio Olveira et al. · 2025 · Gastroenterología y Hepatología (English Edition)
  13. Gastric Antral Vascular Ectasia as the First Presentation of Primary Biliary Cholangitis
    Sugata Narayan Biswas, Anshuman Elhence, Vinita Agrawal · 2022 · Cureus
  14. Pruritus and health-related quality of life in chronic liver disease: a longitudinal, survey-based cohort study
    Usha Gungabissoon, Jacob N. Hunnicutt, Eleanor McDermott, Andrew Lovley, Monica Frazer, Kaitlin LaGasse, Mark R. Kosinski, Kristen L. McCausland, Ashleigh A. McGirr, Helen T. Smith et al. · 2025 · BMJ Open Gastroenterology
  15. Impact of Alkaline Phosphatase Normalization on Complication-Free Survival in Primary Biliary Cholangitis
    Anish Reddy, Adrielly Martins, Christopher L. Bowlus, Marlyn J. Mayo, Elizabeth J. Carey, Mark Wong, Michael Weiss, Hany A. Elbeshbeshy, Raymond A. Rubin, Velimir A. Luketic et al. · 2026 · The American Journal of Gastroenterology
  16. PSC and Overlap Syndromes
    Nathalie A. Pena Polanco, Claudia Cottone, Kalyan Ram Bhamidimarri · 2020 · Current Hepatology Reports
  17. TR score: A noninvasive model to predict histological stages in patients with primary biliary cholangitis
    Zhixin Tu, Yao Wang, Yan Wang, Jianjie Huang, Yujin Han, Qijia Ji, Xiaoxuan Cao, Xiaoyu Wen, Yang Wang, Qinglong Jin · 2023 · Frontiers in Immunology
  18. High biochemical remission rates in patients with primary biliary cholangitis treated with “triple” anticholestatic therapy
    Guilherme Grossi Lopes Cançado, Bo Chen, Madeline Cameron, Inbal Houri, Kristel K. Leung, Aliya F. Gulamhusein, Bettina E. Hansen, Gideon Morris Hirschfield · 2025 · Hepatology Communications
  19. Autoantibodies in Primary Biliary Cholangitis: From Classical Markers to Emerging Targets
    Shima Mimura, Asahiro Morishita, Kyoko Oura, Rie Yano, M. Nakahara, Tomoko Tadokoro, Koji Fujita, Joji Tani, Miwa Tatsuta, Takashi Himoto et al. · 2025 · Journal of Clinical Medicine
  20. Treatment of Primary Biliary Cholangitis including Transplantation
    Yasameen Muzahim, Ali Wakil, Mehak Bassi, Nikolaos Pyrsopoulos · 2023 · Clinics in Liver Disease
  21. Increased risk of fragility fractures in patients with primary biliary cholangitis
    Jihye Lim, Ye‐Jee Kim, Sehee Kim, Jonggi Choi · 2024 · JBMR Plus
  22. Diagnostic value of quantitative chemiluminescence immunoassay for anti-gp210 and anti-sp100 antibodies in primary biliary cholangitis
    Yazhen Zhang, Yujiao Jin, Yuan Liu · 2024 · Clinical Chemistry and Laboratory Medicine (CCLM)
  23. Bile acid therapy for primary biliary cholangitis: Pathogenetic validation
    Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev · 2024 · World Journal of Experimental Medicine
  24. Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis
    Kris V. Kowdley, Cynthia Levy, David Jones · 2024 · New England Journal of Medicine
  25. Inflammatory Demyelinating Pseudotumor With Liver Dysfunction: IgG4 Related Disease With Primary Biliary Cholangitis
    Ning Tang, Yingbin Jiao, Yan Wang · 2020 · The American Journal of the Medical Sciences
  26. Primary biliary cholangitis: assessment and management strategies
    S Nadir Abbas, David E. Jones, Yiannis N. Kallis, Laura Maher, Imran Patanwala · 2021 · Gastrointestinal Nursing
  27. Quality of Life in Patients With Variant Syndromes of Autoimmune Liver Diseases—A Cross‐Sectional Multicentre Study
    Natalie Uhlenbusch, Romée J.A.L.M. Snijders, Meike Mund, Maciej K. Janik, Piotr Milkiewicz, Bernd Löwe, Claudia Kroll, Joanna Raszeja‐Wyszomirska, Alessio Gerussi, Francesca Bolis et al. · 2026 · Liver International
  28. Association of CCR6 functional polymorphisms with Primary Biliary Cholangitis
    Mingming Zhang, Zhuye Qin, Yexi Huang, Wenyan Tian, You Li, Chan Wang, Weifeng Zhao, Yaping Dai, Xingjuan Shi, Merrill Eric Gershwin et al. · 2024 · Journal of Translational Autoimmunity
  29. Association between ursodeoxycholic acid use and COVID-19 in individuals with chronic liver disease: a nationwide case-control study in South Korea
    Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek · 2024 · Virology Journal
  30. Colangitis biliar primaria: experiencia de cinco años en el Hospital Clínico de la Universidad de Chile
    Felipe Ramírez, Alvaro M. Urzua, Juan Pablo Roblero, Máximo Cattaneo, Carmen Hurtado, Jaime Poníachik · 2022 · Revista médica de Chile
  31. A new and simple score to predict adequate and deep response to ursodeoxycholic acid in patients with primary biliary cholangitis: the ALP-A score
    Guilherme Grossi Lopes Cançado, Nathália Mota de Faria Gomes, Cláudia Alves Couto, Eduardo Luiz Rachid Cançado, Débora Raquel Benedita Terrabuio, Cristiane Alves Villela‐Nogueira, Michelle Harriz Braga, Mateus Jorge Nardelli, Luciana Costa Faria, Elze Maria Gomes Oliveira et al. · 2024 · European Journal of Gastroenterology & Hepatology
  32. Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis
    Ida Henriksson, Ruzan Udumyan, Emma Nilsson, Kristina Önnerhag, Fredrik Rorsman, Mårten Werner, Hanns–Ulrich Marschall, Staffan Wåhlin, Nils Nyhlin, SweHep · 2022 · Scandinavian Journal of Gastroenterology
  33. Approach to Abnormal Liver Biochemistries in the Primary Care Setting
    R. Rajesh, Aditya Sangameshwar, Yi Yuan Tan, Kevin Teh Kim Jun, Tat Yean Tham, Mark Chang Chuen Cheah · 2024 · Cureus
  34. Excellent outcome in patients with primary biliary cholangitis in Northwest Italy followed up for up to 30 years
    Cristina Rigamonti, Carla De Benedittis, Sara Labanca, Ester Vanni, Anna Morgando, Giulia Francesca Manfredi, Danila Azzolina, Micol Giulia Cittone, Edoardo Giovanni Giannini, Giorgio Maria Saracco et al. · 2023 · European Journal of Gastroenterology & Hepatology
  35. CCL26 in primary biliary cholangitis – Is it a novel disease mediator?
    Xiaochuan Sun, Yihan Cao, Li Wang, Hua Chen, Fengchun Zhang · 2023 · International Journal of Rheumatic Diseases
  36. Pathophysiologic Basis for Alternative Therapies for Cholestasis
    Claudia Daniela Fuchs, Emina Halilbasic, Michael A Trauner · 2020 · Wiley eBooks
  37. Can simple non-invasive fibrosis models determine prognostic indicators (fibrosis and treatment response) of primary biliary cholangitis?
    Süleyman Sayar · 2021 · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital
  38. Recurrent primary biliary cholangitis after liver transplantation: A global meta-analysis of epidemiology and risk factors
    Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Mariana Macambira Noronha, Yohanna Idsabella Rossi, Isabelle Castro Vitor, Milena Ramos Tomé, Wellgner Fernandes Oliveira Amador, Igor Boechat Silveira, Marina de Assis Bezerra Cavalcanti Leite, Rodrigo Vieira Motta et al. · 2025 · American Journal of Transplantation
  39. Primary Biliary Cholangitis Pathogenesis: A Pathophysiology-Based Narrative Review
    Klairi Papachristou, Maria Angelara, Konstantinos Manganas, Θεόδωρος Ανδρουτσάκος · 2026 · International Journal of Molecular Sciences
  40. Clinical characterization of patients with primary biliary cholangitis: A report from multiple Canadian centres
    Eric M. Yoshida, Mark G. Swain, Cynthia D Tsien, Edward Tam, Robert James Bailey, Dusanka Grbic, Hin Hin Ko, Alnoor S. Ramji, Nir Hilzenrat, Magdy Elkhashab et al. · 2022 · Canadian Liver Journal
  41. Anti-centromere antibody positivity with coexisting idiopathic portal hypertension and primary biliary cholangitis progressing to limited cutaneous systemic sclerosis: a case report
    Yuya Ando, Suguru Mabuchi, Norikazu Mataki, Satoshi Nakayama, Arata Honda, Mari Kamiya, Shinsuke Yasuda, Hiroaki Takeo, Shigeaki Aono, Masayoshi Hashimoto et al. · 2025 · Journal of Medical Case Reports
  42. Inborn Errors of Immunity in Adults with Autoimmune Liver Diseases
    Şefika Nur Ayar, Elif Soyak Aytekin, Cem Şimşek · 2024 · The Turkish Journal of Gastroenterology
  43. Adverse events associated with obeticholic acid: a real-world, pharmacovigilance study
    Chunxia Zhang, Jianguo Wang · 2025 · Expert Opinion on Drug Safety
  44. New‐onset primary biliary cholangitis in anti‐mitochondrial antibody‐positive patients may be underestimated without liver biopsy
    Zaixing Yang, Y. Liang · 2020 · Journal of Internal Medicine
  45. Linee guida SIPMeL per la determinazione degli autoanticorpi nella diagnosi delle malattie autoimmuni del fegato
    Maria Concetta Sorrentino, a nome del GdS-AI SIPMeL, Teresa Carbone, Luigi Cinquanta, Maria Grazia Alessio, Maria Giaele Infantino, Gaia Deleonardi, Maria T. TREVISAN, Brunetta Porcelli, Lucia Terzuoli et al. · 2024 · La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine
  46. Treatment of primary biliary cirrhosis with ursodeoxycholic acid combined with traditional Chinese medicine
    Xing Chen, Xiao Ma, Ruilin Wang, Lifu Wang, Jianyu Li, Honghong Liu, Tingting He, Shizhang Wei, Haotian Li, Min Wang et al. · 2020 · Medicine
  47. Update der S3-Leitlinie „Seltene Lebererkrankungen (LeiSe LebEr) – Autoimmune Lebererkrankungen von der Pädiatrie bis zum Erwachsenenalter“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – Living guideline
    Marcial Sebode, Heike Bantel, Ulrich Baumann, Philip Bufler, Münevver Demir, Leona Dold, Verena Keitel, Reinhild Klein, Andreas Emanuel Kremer, Petra Lynen Jansen et al. · 2026 · Zeitschrift für Gastroenterologie
  48. Prognostic significance of serum tyrosine concentration in patients with primary biliary cholangitis under ursodeoxycholic acid therapy
    Nozomi Amano, Yuji Ikeda, Sho Hayashida, Sho Takahashi, Sho Sato, Ayato Murata, Hironori Tsuzura, Shunsuke Sato, Yuji Shimada, Katsuyori Iijima et al. · 2019 · Hepatology Research
  49. Comparative characteristics of the clinical and laboratory features of the primary Sjogren’s syndrome associated with anticentromere antibodies and the “classic” subtype of the disease
    B. D. Chaltsev, V. I. Vasiliev, S G Palshina · 2021 · Rheumatology Science and Practice
  50. Fluctuations of antimitochondrial antibodies and anti-gp210 antibody in a patient with primary biliary cholangitis and Sjögren syndrome with subsequent autoimmune hemolytic anemia
    Dantong Zhao, Yanmin Liu, Ying Han, Haiping Zhang, Yan Zhao, Huiping Yan · 2020 · Medicine
  51. Primary Biliary Cholangitis
    Nora V. Bergasa · 2021 · Springer eBooks
  52. Prognostic Significance of Bile Duct Loss in Early‐Stage Primary Biliary Cholangitis: A Long‐Term Observational Study
    Taiki Okumura, Takefumi Kimura, Takanobu Iwadare, Shun‐ichi Wakabayashi, Hiroyuki Kobayashi, Yūki Yamashita, Satoru Joshita, Michiharu Komatsu, Naoki Tanaka, Akihiro Matsumoto et al. · 2025 · Hepatology Research
  53. The Many Faces of Primary Sclerosing Cholangitis: Controversy Abounds
    Brian J. Wentworth, Rachita Khot, Stephen Hugh Caldwell · 2023 · Digestive Diseases and Sciences
  54. Gastroesophageal varices in primary biliary cholangitis with anti-centromere antibody positivity: Early onset?
    Han Shi, Qi Wang, Hui Liu, Bin Xu, Yanmin Liu, Juan Zhao, Lina Sun, Dexi Chen, Chunyang Huang, Rong-Hua Jin · 2024 · Open Life Sciences
  55. Clinical Performance of the Line Immunoassay and Digital Liquid Chip Method for Detecting Autoimmune Liver Disease Autoantibodies
    Heye Lv, Ao Deng, Yijun Chen, Zhenzhen Su · 2024 · Archives of Pathology & Laboratory Medicine
  56. Pruritus, Fatigue, Osteoporosis and Dyslipoproteinemia in Pbc Patients: A Clinician’s Perspective
    Sylvia Dražilová, Tomáš Koky, Marian Macej, Martin Janíčko, Dagmar Simkova, Ariunzaya Tsedendamba, С.Г. Комарова, Peter Jarčuška · 2024 · Gastroenterology Insights
  57. Diagnostic performance of FibroTest-ActiTest, transient elastography, and the fibrosis-4 index in patients with autoimmune hepatitis using histological reference
    Valentina Peta, Yu.G. Sandler, Olivier Deckmyn, Oksana Duroselle, E. V. Vinnitskaya, Sergey Khomeriki, Karina K. Noskova, Thierry Poynard · 2025 · World Journal of Hepatology
  58. Machine learning prediction model for treatment responders in patients with primary biliary cholangitis
    Naruhiro Kimura, Kazuya Takahashi, Toru Setsu, Shu Goto, Suguru Miida, Nobutaka Takeda, Yuichi Kojima, Yoshihisa Arao, Kazunao Hayashi, Norihiro Sakai et al. · 2023 · JGH Open
  59. Interactions of Drugs for Liver Diseases
    Marina Mudrovčić, Lucija Virović Jukić, Doris Ogresta, Ivica Grgurević · 2024 · Clinical gastroenterology
  60. Noninvasive elastography-based assessment of liver fibrosis in primary biliary cholangitis
    Xiaohui Ye, Lingling He, Caihong Deng, Junru Yang, Ping Li, Hongshan Wei · 2025 · Annals of Hepatology
  61. Increased sensitivity of gp210 autoantibody detection using a newly designed gp210 antigen
    Jing Xu, Haoyi Zhang, Chan Wang, Peng Jiang, Chongxu Han, Yaping Dai, Fang Qiu, Yuhua Gong, Yuzhang Jiang, Ping Xu et al. · 2021 · Journal of Immunological Methods
  62. Pathogenesis and Systemic Treatment of Hepatocellular Carcinoma: Current Status and Prospects
    Wanting Lei, Kexun Zhou, Ye Lei, Qiu Li, Hong Zhu · 2024 · Molecular Cancer Therapeutics
  63. Pathophysiology of biochemical signs of primary biliary cholangitis
    Vasiliy Ivanovich Reshetnyak, Igor Veniaminovich Maev · 2023 · Exploration of Digestive Diseases
  64. Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
    Ciro Manzo, Maria Maślińska, Alberto Castagna, Elvis Hysa, Alfonso Merante, Marcin Milchert, Tiziana Gravina, Betül Sargın, Maria Natale, Carmen Ruberto et al. · 2021 · Medicina
  65. Protective effects of Polygonum cuspidatum bioactive constituents against cholestatic liver injury: A mechanistic review
    Zengni Zhang, Xiao Yang, Yan Fu, Huilin Wei, Yajuan Chen, Anlin Dai, Xia Zhou, Jun Wan, Wenwen Chen · 2025 · Fitoterapia
  66. Prevalence of Celiac Disease in Patients With Primary Biliary Cholangitis: A Systematic Review and Meta‐Analysis
    Fabiana Zingone, Cristina Canova, Anders Forss, Fahim Ebrahimi, Nora Cazzagon, Isabella Rosato, Jonas Filip Ludvigsson · 2025 · Liver International
  67. High frequency of ABCB4 and ABCB11 gene variants in adult patients with idiopathic chronic or recurrent cholestasis
    Paulo Lisboa Bittencourt, Vivian Rotman, Liana Codés, Antônio Ricardo Cardia Ferraz de Andrade, Raimundo Araújo Gama, Lívia Geovana Falcão Barbosa Celestino, Raymundo Paraná, Maria Lúcia Gomes Ferraz, Larissa Sampaio de Athayde, Richard J. Thompson et al. · 2025 · Hepatology Communications
  68. Liver transplant outcomes in primary biliary cholangitis and metabolic dysfunction-associated steatotic liver disease overlap
    Leandro Sierra, Shahana Prakash, Jamak Modaresi Esfeh, Omar T. Sims, Dian Jung Chiang · 2026 · Annals of Hepatology
  69. Secondary Treatment of Primary Biliary Cholangitis: Early Prediction of Inadequate Response to Ursodeoxycholic Acid in Patients with PBC
    B. Liu, K. Qureshi · 2022 · Digestive Diseases and Sciences
  70. Tumor necrosis factor alpha-induced protein 3: A key biomarker for response to ursodeoxycholic acid in primary biliary cholangitis
    Bo Zang, Jiaxiu Li, Qi-Xuan Liu, Yuan Yao, Hua Li, Yan Wang, Jigang Wang, Yifei Yang, Ruiwen Liang, Xin-Ran Xin et al. · 2025 · World Journal of Hepatology
  71. Seladelpar in patients with primary biliary cholangitis and compensated cirrhosis: Efficacy and safety from RESPONSE and ASSURE studies
    Stuart C. Gordon, Alejandra Villamil, Ira M. Jacobson, Eric Lawitz, Ziad H Younes, Marina G. Silveira, Christopher L. Bowlus, Joost P.H. Drenth, John Moore Vierling, Ulrike Morgera et al. · 2026 · Hepatology Communications
  72. Primary Biliary Cholangitis in 2025: A New Frontier
    Hannah R. Klatzkow, Indira Bhavsar‐Burke, Meredith M. Pearson, Brian J. Wentworth · 2025 · The American Journal of Gastroenterology
  73. Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions
    Jiaorong Qu, Wenqing Qin, Minghang Dong, Zhi Ma, Si Li, Liu R, Ranyun Chen, C H Li, X Li · 2026 · MedComm
  74. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape
    Aalam Sohal, Kris V. Kowdley · 2024 · Expert Opinion on Investigational Drugs
  75. The relationship between CXCR6+CD8+T cells and clinicopathological parameters in patients with primary biliary cholangitis
    Huilian Shi, Xiangtao Xu, Shuangshuang Wang, Qinlei Chen, Fan Zhang, Haiyan Guo, Weiting Lu, Fei Qiao · 2024 · Hepatology International
  76. EASL-AASLD Delphi consensus statement on surrogate endpoints and real-world evidence in primary biliary cholangitis
    Cynthia Levy, Ana Lleo, Adrielly Martins, Miki Scaravaglio, Christopher L. Bowlus, Marco Carbone, Christophe Corpechot, Cláudia Alves Couto, Bettina E. Hansen, Gideon Morris Hirschfield et al. · 2026 · Journal of Hepatology
  77. Seladelpar Improves Cholestasis and Pruritus in Obeticholic Acid and Fibrate-Experienced Patients With Primary Biliary Cholangitis
    Gordon Sv, Sarah Proehl, Daniel Pratt · 2026 · Clinical Gastroenterology and Hepatology
  78. Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: a retrospective cohort study
    Huanqiao Zhong, Mengyao Zheng, Chunmei Zhao, Qun Wei, Zhiyan Ou, Tianyun Wang, Ning Li, Zhitian Shi, Sidi Li, Yao Yao et al. · 2026 · BMC Gastroenterology
  79. Autotaxin: A Potential biomarker for primary biliary cholangitis
    Yifei Yang, Bingqian Liu, Bo Zang, Qixuan Liu, Chenyang Zhao, Yuan Yao, Bin Liu · 2023 · Heliyon
  80. Long‐Term Use of Fenofibrate as Second‐Line Therapy in Primary Biliary Cholangitis: A Retrospective Study
    Mariko Maxwell, Yanhong Deng, Bonnie Chen, Marina G. Silveira, James Lorenzen Boyer, David N. Assis · 2026 · Alimentary Pharmacology & Therapeutics
  81. Bile Duct Diseases
    Yoh Zen, Stefan G. Hübscher, Yasuni Nakanuma · 2023 · Elsevier eBooks
  82. Association of sarcopenia assessed by CT/MRI with treatment response and clinical outcomes in noncirrhotic primary biliary cholangitis patients
    Leyu Zhou, Bo Li, Zhetao Wang, Xiaoyan Ao, Xianglin Wang, Yanyi Zheng, Yazhou He, Xiaoli Fan, Li Yang · 2025 · European Journal of Radiology
  83. Primary Biliary Cholangitis
    Atsushi Tanaka, Patrick S.C. Leung, Christopher L. Bowlus, Merrill Eric Gershwin · 2020 · Springer eBooks
  84. Gender-specific development of experimental autoimmune cholangitis induced by double-stranded RNA
    Shunin Someya, Akira Uchiyama, Kumiko Arai, Kazuyoshi Kon, Shunhei Yamashina, Sumio Watanabe, Kenichi Ikejima · 2021 · Biochemical and Biophysical Research Communications
  85. Acute coronary syndrome after liver transplantation in a young primary biliary cholangitis recipient with dyslipidemia: a case report
    Siyuan Yao, Akiho Iwashita, Shintaro Yagi · 2022 · Surgical Case Reports
  86. Antimitochondrial Antibody-Negative Primary Biliary Cholangitis: A Retrospective Diagnosis
    Rami Al-Handola, Justine M. Chinnappan, Murtaza Shabbir Hussain, Abdullahi Elsheikh Mahgoub, Ghassan I. Bachuwa · 2023 · Cureus
  87. Pharmacovigilance of obeticholic acid: An analysis of the Food and Drug Administration Adverse Event Reporting System database
    Qining He, Mengting Jiang, Yuchen Wang, Tao Zheng · 2025 · British Journal of Clinical Pharmacology
  88. MicroRNA-126-3p as a predictive biomarker for patients with primary biliary cholangitis refractory to ursodeoxycholic acid
    Shi-Da Pan, Chu-Yue Xiong, Ying-Juan Shen, Jiahe Tian, Yilin Wang, Jia‐Ning Wang, Siyu Wang, Fengyi Li, Lifeng Wang, Qin Qiu et al. · 2025 · World Journal of Gastroenterology
  89. Colangitis biliar primaria: caracterización de una cohorte retrospectiva
    Edgar Fernando Ayala-Sierra, Octavio Germán Muñoz Maya, Felipe Guerrero-Pérez, Manuela Cardona-Jaramillo · 2022 · Hepatología
  90. Dysregulation of Farnesoid X Receptor on Neutrophil Homeostasis Exacerbates Intestinal Inflammation via the mTORC1‐Glycolysis Signaling Pathway
    Dengfeng Kang, Ai Q. Li, Xiangqi Xie, Han Liu, Liang Chen, Zhongsheng Feng, Xiang Gao, Han Gao, Xiaohan Wu, Huiying Lu et al. · 2026 · MedComm
  91. The Role of Bezafibrate, a Peroxisome Proliferator‐Activated Receptor Alpha Agonist, in Patients With Primary Biliary Cholangitis
    Daniel Stephan Pratt · 2019 · Hepatology
  92. Application Value of Novel Inflammatory Indicators in Response to Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis
    Siqi Liu, Yongli Pang, Xiaoxi Wang, Ruihang Lin, Siqing Tunala · 2025 · International Journal of General Medicine
  93. Autoantibodies in the diagnostics, prognostics and follow-up of primary biliary cholangitis
    Péter Antal‐Szalmás, Dóra Bencze, Sarolta Demeter, Krisztina Pénzes, Lilla Szabó, Beáta Tóth, Róza Földesi, Mária Papp, Gábor Nagy · 2026 · Journal of Translational Autoimmunity
  94. Primary Biliary Cholangitis
    2017 · Elsevier eBooks
  95. Real-world performance of transient elastography in assessing advanced fibrosis in Chinese patients with primary biliary cholangitis
    Jialiang Chen, Yixin Hou, Yao Liu, Yuyong Jiang, Xianbo Wang · 2025 · World Journal of Gastroenterology
  96. Registry of patients with autoimmune liver diseases in St. Petersburg: clinical and epidemiological data
    Игорь Геннадьевич Бакулин, Svetlana A. Burlakova, Сказываева Екатерина Васильевна, Maria I. Skalinskaya · 2024 · HERALD of North-Western State Medical University named after I I Mechnikov
  97. An observational study of the causes of an isolated elevated alkaline phosphatase level of unclear etiology
    William Stephen Jones, Don C. Rockey · 2024 · The American Journal of the Medical Sciences
  98. Serum microRNA 143 and 223 Gene Expression Profiles as Potential Biomarkers in Individuals with Hepatitis and COVID-19
    Lucas Lima da Silva, Luciane Almeida Amado Leon, Otacílio C. Moreira · 2024 · Viruses
  99. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases
    Henrique Carvalho Rocha, Eduardo García Vilela · 2022 · Gastroenterología y Hepatología (English Edition)
  100. Leukemia inhibitory factor promotes human cholangiopathies, and its inhibition improves cholestasis in Abcb4 −/− mice
    Cristina Di Giorgio, Ginevra Urbani, Carmen Massa, Silvia Marchianò, Michele Biagioli, Martina Bordoni, Ginevra Lachi, Benedetta Sensini, Rachele DEL SORDO, Francesca Paniconi et al. · 2025 · Hepatology Communications